Affiliation: National Center for Epidemiology
- The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutrimentZoltán Marcsek
National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, Budapest, Hungary
Cancer Biother Radiopharm 19:746-53. 2004..As apoptosis increased when Avemar was added to tamoxifen treatment, the use of supplementary therapy with Avemar in the case of ER+ breast tumors may enhance the therapeutic effects of tamoxifen...
- Effect of simultaneous administration of Avemar and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival tumor-bearing miceBela Szende
National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, 1450 Budapest, Hungary
Cancer Biother Radiopharm 19:343-9. 2004..Avemar may be administered together with cytostatic drugs, without the risk of increasing toxicity or decreasing antiproliferative activity...